Zetia, a cholesterol-lowering drug prescribed to approximately 1 million people weekly, gives no medical benefits, according to a trial by Merck and Schering-Plough the New York Times reported in an article in January of this year.
While the pill does lower cholesterol by fifteen percent to twenty percent, trials haven’t proven that Zetia reduces heart attacks or strokes, or that it reduces the amount of plaque in arteries that can lead to heart issues.
  Discover 3 Natural Remedies That Will Stop Virtually Any Pain

The trial, which analyzed whether Zetia had the ability to reduce the growth of plaques, determined that plaques developed almost twice as fast in patients taking Zetia together with Zocor than in those taking Zocor alone.
Those patients who took both Zetia combined with Zocor took it in the form of Vytorin, a pill that merges the medications. Experts have been astonished they have called the results “shocking,” declaring that Zetia should not be prescribed unless all other cholesterol has been unsuccessful.

The results also contributed to the controversy over Merck and Schering-Plough’s delays in releasing them. The trial was completed in April of 2006, and the results were scheduled to be released in March 2007. Notwithstanding, the companies missed numerous deadlines, and only agreed to release the results after the media begin to focus on their continuing delays.

Prostate Alternative? Maximum Prostate 3000 More Powerful Than Saw Palmetto!

Zeta and Vitoria account for approximately 20 percent of the cholesterol drugs on the U.S. market.

Keith M Henry is the Director of phase 3ministries, based in Orlando FL. He is medical missionary herbalist, and Naturopathic doctor candidate. Download your free copy of his report, Emergency Herbal Medicine, HERE . It may very well save your life.